A Role for Decision Analysis in PHIAC? Mark Sculpher Centre for Health Economics University of York.

Slides:



Advertisements
Similar presentations
What is a review? An article which looks at a question or subject and seeks to summarise and bring together evidence on a health topic.
Advertisements

Technology Appraisal of Medical Devices at NICE – Methods and Practice Mark Sculpher Professor of Health Economics Centre for Health Economics University.
USE OF EVIDENCE IN DECISION MODELS: An appraisal of health technology assessments in the UK Nicola Cooper Centre for Biostatistics & Genetic Epidemiology,
USE OF EVIDENCE IN DECISION MODELS: An appraisal of health technology assessments in the UK Nicola Cooper Centre for Biostatistics & Genetic Epidemiology,
Study Objectives and Questions for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Protocol Development.
Dangerous Omissions: The Consequences of Ignoring Decision Uncertainty Karl Claxton Centre for Health Economics*, Department of Economics and Related Studies,
Global Dimension Resources. Importance of Resources Global dimension covers such a vast area necessitates usage of range of material outside teacher’s.
How can we show that links projects are making a difference? Dr Kay Richmond Dr Diane Kirkland Dr Sally Venn.
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
Evidence Based Advertising “Don’t accept your dog’s admiration as conclusive evidence that you are wonderful” -Ann Landers.
Exploring uncertainty in cost effectiveness analysis NICE International and HITAP copyright © 2013 Francis Ruiz NICE International (acknowledgements to:
HERU is supported by the Chief Scientist Office of the Scottish Government Health Directorates and the University of Aberdeen. The author accepts full.
“Rational Pharmacology” and Health Economics By Alan Maynard.
MPS Research UnitCHEBS Workshop - April Anne Whitehead Medical and Pharmaceutical Statistics Research Unit The University of Reading Sample size.
Shared decision making and Australian general practitioner training Dr Ronald McCoy, Education Strategy Senior Advisor, Royal Australian College of General.
Optimal Drug Development Programs and Efficient Licensing and Reimbursement Regimens Neil Hawkins Karl Claxton CENTRE FOR HEALTH ECONOMICS.
Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare.
Undertaking Systematic Literature Reviews By Dr. Luke Pittaway Institute for Entrepreneurship and Enterprise Development.
The role of economic modelling – a brief introduction Francis Ruiz NICE International © NICE 2014.
The Importance of Decision Analytic Modelling in Evaluating Health Care Interventions Mark Sculpher Professor of Health Economics Centre for Health Economics.
Cost-Effectiveness Analyses in the UK - Lessons from the National Institute for Clinical Excellence Mark Sculpher Professor of Health Economics Centre.
Structural uncertainty from an economists’ perspective
The Cost-Effectiveness and Value of Information Associated with Biologic Drugs for the Treatment of Psoriatic Arthritis Y Bravo Vergel, N Hawkins, C Asseburg,
Dangerous Omissions – the Cost of Ignoring Decision Uncertainty Mark Sculpher Susan Griffin Karl Claxton Steve Palmer Centre for Health Economics, University.
1/55 EF 507 QUANTITATIVE METHODS FOR ECONOMICS AND FINANCE FALL 2008 Chapter 10 Hypothesis Testing.
The Use of Economic Evaluation For Decision Making: Methodological Opportunities and Challenges Mark Sculpher Karl Claxton Centre for Health Economics.
Journal Club Alcohol and Health: Current Evidence March-April 2006.
The Role of Trial-based Economic Evaluation in Health Care Decision Making Discussion Mark Sculpher Centre for Health Economics University of York iHEA,
QM Spring 2002 Business Statistics Sampling Concepts.
Problem Identification
Health care decision making Dr. Giampiero Favato presented at the University Program in Health Economics Ragusa, June 2008.
Prioritising HTA funding: The benefits and challenges of using value of information in anger CENTRE FOR HEALTH ECONOMICS K Claxton, L Ginnelly, MJ Sculpher,
Trial Based Economic Evaluation: Just Another Piece Of Evidence Claxton K Department of Economics and Centre for Health Economics, University of York,
Decision Analysis as a Basis for Estimating Cost- Effectiveness: The Experience of the National Institute for Health and Clinical Excellence in the UK.
Health Systems and the Cycle of Health System Reform
Identifying evidence for decision-analytic models Suzy Paisley DoH Research Scientist in Evidence Synthesis Consensus Working Group on the Use of Evidence.
Guidelines for the reporting of evidence identification in decision models: observations and suggested way forward Louise Longworth National Institute.
DISCUSSION Alex Sutton Centre for Biostatistics & Genetic Epidemiology, University of Leicester.
The National Institute for Clinical Excellence in the UK – Experience and Impact Mark Sculpher Professor of Health Economics Centre for Health Economics.
Their contribution to knowledge Morag Heirs. Research Fellow Centre for Reviews and Dissemination University of York PhD student (NIHR funded) Health.
Reporting & Ethical Standards EPSY 5245 Michael C. Rodriguez.
Mark Sculpher, PhD Professor of Health Economics University of York, UK LMI, Medicines Agency in Norway and the Norwegian Knowledge Centre for the Health.
Evidence Based Practice
My Own Health Report: Case Study for Pragmatic Research Marcia Ory Texas A&M Health Science Center Presentation at: CPRRN Annual Grantee Meeting October.
Evaluating the Options Analyst’s job is to: gather the best evidence possible in the time allowed to compare the potential impacts of policies.
Multi-Agency Planning in Practice Skill development workshop.
Systematic Reviews.
The return of the 5 year plan Mathematical programming for allocation of health care resources David Epstein, Karl Claxton, Mark Sculpher (CHE) Zaid Chalabi.
Successful Concepts Study Rationale Literature Review Study Design Rationale for Intervention Eligibility Criteria Endpoint Measurement Tools.
Brought to you by: What is Shared Decision Making? Why is it important?
Conducting and Reading Research in Health and Human Performance.
The Major Steps of a Public Health Evaluation 1. Engage Stakeholders 2. Describe the program 3. Focus on the evaluation design 4. Gather credible evidence.
Advanced Higher Modern Studies Research Methods Research Methods.
Information on ethnic minorities and demographic data from asthma clinical trials does not reach the public domain Evidence from a systematic review and.
PANEL SESSION: MODELLING HETEROGENEITY IN COST-EFFECTIVENESS ANALYSIS Modelling variation for decision making Mark Sculpher, PhD Centre for Health Economics,
Matching Analyses to Decisions: Can we Ever Make Economic Evaluations Generalisable Across Jurisdictions? Mark Sculpher Mike Drummond Centre for Health.
Guidelines Recommandations. Role Ideal mediator for bridging between research findings and actual clinical practice Ideal tool for professionals, managers,
Research Design Evidence Based Medicine Concepts and Glossary.
Pilot and Feasibility Studies NIHR Research Design Service Sam Norton, Liz Steed, Lauren Bell.
European Patients’ Academy on Therapeutic Innovation Ethical and practical challenges of organising clinical trials in small populations.
Evidence Based Practice (EBP) Riphah College of Rehabilitation Sciences(RCRS) Riphah International University Islamabad.
The Value of Reference Case Methods for Resource Allocation Decision Making Mark Sculpher, PhD Professor of Health Economics Centre for Health Economics.
Dr. Aidah Abu Elsoud Alkaissi An-Najah National University Employ evidence-based practice: key elements.
PRAGMATIC Study Designs: Elderly Cancer Trials
Supplementary Table 1. PRISMA checklist
Health care decision making
Using Evidence For Better Health Policy
Professor of Health Economics
Presentation transcript:

A Role for Decision Analysis in PHIAC? Mark Sculpher Centre for Health Economics University of York

Rationale for decision analysis Contrasting paradigms Measurement Testing hypotheses about individual endpoints (parameters) Relatively few parameters of interest Primary role for trials and other primary data collection Focus on parameter uncertainty Decision making What do we do now based on all sources of current knowledge? Decision making involves synthesis Decisions cannot be avoided A decision is always taken under conditions of uncertainty Can be based on implicit or explicit analysis 

Key elements of decision analysis Option A Option B Option C Population Outcome 1 Outcome 2 Outcome 1 Outcome 2 Outcome 1 Outcome 2 p1 p2 p3 p4 p5 p6 Value A1 Value A2 Value B1 Value B2 Value C1 Value C2 (p1 x Value A1 ) + (p2 x Value A2 ) Expected value (p3 x Value B1 ) + (p4 x Value B2 ) (p5 x Value C1 ) + (p6 x Value C2 )

Key features of decision analysis Quantitative Explicit Accepts role of judgements/assumptions Helps to understand implications of uncertainty

Example – lead poisoning in children Brown MJ. Medical Decision Making 2002; 22: 482.

Key role for sensitivity analysis Brown MJ. Medical Decision Making 2002; 22: 482.

What would decision analysis require of PHIAC? Absolute clarity about the appropriate population and relevant options (i.e. the ‘decision question’) Clear view about objectives –Health gain –Issue of equity Appropriateness of expected value maximisation Appropriate synthesis for all parameters –Dealing with heterogeneity Random effects Increase options Sub-groups –Not just trial evidence –Dealing with ‘no evidence’ Role for explicit opinion and judgement